REVIEW ARTICLE |
|
Year : 2022 | Volume
: 8
| Issue : 3 | Page : 279-313 |
|
Traditional Chinese medicines against COVID-19: A global overview
Chang-Liang Yao1, Wen-Long Wei1, Jian-Qing Zhang1, Qi-Rui Bi1, Jia-Yuan Li1, Ikhlas Khan2, Rudolf Bauer3, De-An Guo1
1 Shanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Laboratory Research Center for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China 2 National Center for Natural Products Research, School of Pharmacy, University of Mississippi, MS, USA 3 Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
Correspondence Address:
Prof. De-An Guo Shanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Laboratory Research Center for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Haike Road 501, Shanghai, 201203 China
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/2311-8571.353502
|
|
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, continues to be a global concern. Traditional Chinese medicines (TCMs) are an important element of the fight against COVID-19 in China. The combined application of TCMs and conventional medicines in the treatment of COVID-19 has achieved beneficial results, including the resolution of symptoms, prevention of disease progression, and reduced mortality. In this review, we summarize and discuss the current applications of TCMs with respect to COVID-19, as well as update the preclinical and clinical research, including chemical analysis, molecular mechanisms, quality control, drug development, and studies of clinical efficacy. The expectation is that a better understanding of the roles of TCMs against COVID-19 will improve the response to COVID-19, both in China and globally.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|